Literature DB >> 17377847

Optimization of biaryl piperidine and 4-amino-2-biarylurea MCH1 receptor antagonists using QSAR modeling, classification techniques and virtual screening.

Georgia Melagraki1, Antreas Afantitis, Haralambos Sarimveis, Panayiotis A Koutentis, John Markopoulos, Olga Igglessi-Markopoulou.   

Abstract

This paper presents the results of an optimization study on biaryl piperidine and 4-amino-2-biarylurea MCH1 receptor antagonists, which was accomplished by using quantitative-structure activity relationships (QSARs), classification and virtual screening techniques. First, a linear QSAR model was developed using Multiple Linear Regression (MLR) Analysis, while the Elimination Selection-Stepwise Regression (ES-SWR) method was adopted for selecting the most suitable input variables. The predictive activity of the model was evaluated using an external validation set and the Y-randomization technique. Based on the selected descriptors, the Support Vector Machines (SVM) classification technique was utilized to classify data into two categories: "actives" or "non-actives". Several attempts were made to optimize the scaffold of most potent compounds by inducing various structural modifications. Potential derivatives with improved activities were identified, as they were classified "actives" by the SVM classifier. Their activities were estimated using the produced MLR model. A detailed analysis on the model applicability domain defined the compounds, whose estimations can be accepted with confidence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17377847     DOI: 10.1007/s10822-007-9112-4

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   4.179


  17 in total

Review 1.  Recognizing molecules with drug-like properties.

Authors:  W P Walters; M A Murcko
Journal:  Curr Opin Chem Biol       Date:  1999-08       Impact factor: 8.822

2.  Beware of q2!

Authors:  Alexander Golbraikh; Alexander Tropsha
Journal:  J Mol Graph Model       Date:  2002-01       Impact factor: 2.518

3.  Comparison of ranking methods for virtual screening in lead-discovery programs.

Authors:  David Wilton; Peter Willett; Kevin Lawson; Graham Mullier
Journal:  J Chem Inf Comput Sci       Date:  2003 Mar-Apr

4.  Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds.

Authors:  Min Shen; Cécile Béguin; Alexander Golbraikh; James P Stables; Harold Kohn; Alexander Tropsha
Journal:  J Med Chem       Date:  2004-04-22       Impact factor: 7.446

5.  Investigation of substituent effect of 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides on CCR5 binding affinity using QSAR and virtual screening techniques.

Authors:  Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Panayiotis A Koutentis; John Markopoulos; Olga Igglessi-Markopoulou
Journal:  J Comput Aided Mol Des       Date:  2006-05-09       Impact factor: 3.686

6.  Synthesis and structure-activity relationships of biarylcarboxamide bis-aminopyrrolidine urea derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1).

Authors:  Martin W Rowbottom; Troy D Vickers; Brian Dyck; Junko Tamiya; Mingzhu Zhang; Liren Zhao; Jonathan Grey; David Provencal; David Schwarz; Christopher E Heise; Monica Mistry; Andrew Fisher; Teresa Dong; Tao Hu; John Saunders; Val S Goodfellow
Journal:  Bioorg Med Chem Lett       Date:  2005-07-15       Impact factor: 2.823

7.  Discovery of 4-(dimethylamino)quinazolines as potent and selective antagonists for the melanin-concentrating hormone receptor 1.

Authors:  Kosuke Kanuma; Katsunori Omodera; Mariko Nishiguchi; Takeo Funakoshi; Shigeyuki Chaki; Graeme Semple; Thuy-Anh Tran; Bryan Kramer; Debbie Hsu; Martin Casper; Bill Thomsen; Nigel Beeley; Yoshinori Sekiguchi
Journal:  Bioorg Med Chem Lett       Date:  2005-05-16       Impact factor: 2.823

8.  Discovery and SAR of biaryl piperidine MCH1 receptor antagonists through solid-phase encoded combinatorial synthesis.

Authors:  Tao Guo; Yuefei Shao; Gang Qian; Laura L Rokosz; Tara M Stauffer; Rachael C Hunter; Suresh D Babu; Huizhong Gu; Doug W Hobbs
Journal:  Bioorg Med Chem Lett       Date:  2005-08-15       Impact factor: 2.823

9.  Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 2.

Authors:  Anil Vasudevan; Dariusz Wodka; Mary K Verzal; Andrew J Souers; Ju Gao; Sevan Brodjian; Dennis Fry; Brian Dayton; Kennan C Marsh; Lisa E Hernandez; Christopher A Ogiela; Christine A Collins; Philip R Kym
Journal:  Bioorg Med Chem Lett       Date:  2004-10-04       Impact factor: 2.823

10.  Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice.

Authors:  Timothy J Kowalski; Brian D Spar; Blair Weig; Constance Farley; John Cook; Lorraine Ghibaudi; Steve Fried; Kim O'Neill; Robert A Del Vecchio; Mark McBriar; Henry Guzik; John Clader; Brian E Hawes; Joyce Hwa
Journal:  Eur J Pharmacol       Date:  2006-03-13       Impact factor: 4.432

View more
  5 in total

1.  A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogs.

Authors:  Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Panayiotis A Koutentis; Olga Igglessi-Markopoulou; George Kollias
Journal:  Mol Divers       Date:  2009-05-30       Impact factor: 2.943

2.  Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors.

Authors:  Georgia Melagraki; Antreas Afantitis; Haralambos Sarimveis; Panayiotis A Koutentis; George Kollias; Olga Igglessi-Markopoulou
Journal:  Mol Divers       Date:  2009-02-10       Impact factor: 2.943

3.  Benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one derivatives as Aurora A kinase inhibitors: LQTA-QSAR analysis and detailed systematic validation of the developed model.

Authors:  Ashish M Kanhed; Radha Charan Dash; Nishant Parmar; Tarun Kumar Das; Rajani Giridhar; Mange Ram Yadav
Journal:  Mol Divers       Date:  2015-07-17       Impact factor: 2.943

4.  A QSAR Study of Matrix Metalloproteinases Type 2 (MMP-2) Inhibitors with Cinnamoyl Pyrrolidine Derivatives.

Authors:  Eduardo Borges de Melo
Journal:  Sci Pharm       Date:  2012-01-31

5.  QSAR models for CXCR2 receptor antagonists based on the genetic algorithm for data preprocessing prior to application of the PLS linear regression method and design of the new compounds using in silico virtual screening.

Authors:  Tahereh Asadollahi; Shayessteh Dadfarnia; Ali Mohammad Haji Shabani; Jahan B Ghasemi; Maryam Sarkhosh
Journal:  Molecules       Date:  2011-02-25       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.